Literature DB >> 19010321

TAZ is a coactivator for Pax8 and TTF-1, two transcription factors involved in thyroid differentiation.

Tina Di Palma1, Barbara D'Andrea, Giovanna Lucia Liguori, Annamaria Liguoro, Tiziana de Cristofaro, Dolores Del Prete, Andrea Pappalardo, Anna Mascia, Mariastella Zannini.   

Abstract

Pax8 and TTF-1 are transcription factors involved in the morphogenesis of the thyroid gland and in the transcriptional regulation of thyroid-specific genes. Both proteins are expressed in few tissues but their simultaneous presence occurs only in the thyroid where they interact physically and functionally allowing the regulation of genes that are markers of the thyroid differentiated phenotype. TAZ is a transcriptional coactivator that regulates the activity of several transcription factors therefore playing a central role in tissue-specific transcription. The recently demonstrated physical and functional interaction between TAZ and TTF-1 in the lung raised the question of whether TAZ could be an important regulatory molecule also in the thyroid. In this study, we demonstrate the presence of TAZ in thyroid cells and the existence of an important cooperation between TAZ and the transcription factors Pax8 and TTF-1 in the modulation of thyroid gene expression. In addition, we reveal that the three proteins are co-expressed in the nucleus of differentiated thyroid cells and that TAZ interacts with both Pax8 and TTF-1, in vitro and in vivo. More importantly, we show that this interaction leads to a significant enhancement of the transcriptional activity of Pax8 and TTF-1 on the thyroglobulin promoter thus suggesting a role of TAZ in the control of genes involved in thyroid development and differentiation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19010321     DOI: 10.1016/j.yexcr.2008.10.016

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  31 in total

1.  Regulation and function of the TAZ transcription co-activator.

Authors:  Chenying Liu; Wei Huang; Qunying Lei
Journal:  Int J Biochem Mol Biol       Date:  2011-07-20

Review 2.  Nuclear receptor coregulators: modulators of pathology and therapeutic targets.

Authors:  David M Lonard; Bert W O'Malley
Journal:  Nat Rev Endocrinol       Date:  2012-06-26       Impact factor: 43.330

3.  Molecular cloning and functional characterization of two forms of Pax8 in the rainbow trout, Oncorhynchus mykiss.

Authors:  Nobuto Katagiri; Youji Uemae; Joe Sakamoto; Yoshie Hidaka; Takao Susa; Yukio Kato; Shioko Kimura; Masakazu Suzuki
Journal:  Gen Comp Endocrinol       Date:  2013-12-28       Impact factor: 2.822

4.  High expression of the transcriptional coactivator TAZ is associated with a worse prognosis and affects cell proliferation in patients with medulloblastoma.

Authors:  Hao Wang; Ji Zhou; Dong Yang; Liang Yi; Xuhui Wang; Yangqing Ou; Donghong Yang; Lunshan Xu; Minhui Xu
Journal:  Oncol Lett       Date:  2019-09-11       Impact factor: 2.967

5.  Mutations in TAZ/WWTR1, a co-activator of NKX2.1 and PAX8 are not a frequent cause of thyroid dysgenesis.

Authors:  A M Ferrara; L De Sanctis; G Rossi; S Capuano; G Del Prete; E Zampella; P Gianino; A Corrias; G Fenzi; M Zannini; P E Macchia
Journal:  J Endocrinol Invest       Date:  2009-03       Impact factor: 4.256

6.  Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.

Authors:  Ivette Valencia-Sama; Yulei Zhao; Dulcie Lai; Helena J Janse van Rensburg; Yawei Hao; Xiaolong Yang
Journal:  J Biol Chem       Date:  2015-05-20       Impact factor: 5.157

Review 7.  The mammalian Hippo pathway: regulation and function of YAP1 and TAZ.

Authors:  Manami Kodaka; Yutaka Hata
Journal:  Cell Mol Life Sci       Date:  2014-09-30       Impact factor: 9.261

8.  TAZ Induction Directs Differentiation of Thyroid Follicular Cells from Human Embryonic Stem Cells.

Authors:  Risheng Ma; Syed A Morshed; Rauf Latif; Terry F Davies
Journal:  Thyroid       Date:  2017-01-03       Impact factor: 6.568

9.  Engineered insulin secretion from neuroendocrine cells isolated from human thyroid.

Authors:  Peter M Thulé; Dingwu Jia; Susan Safley; Kereen Gordon; Graham Barber; Hong Yi; Soumya Nalli; Muhittin Onderci; Jyotirmay Sharma; John Shires; Collin J Weber
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

10.  TAZ suppresses NFAT5 activity through tyrosine phosphorylation.

Authors:  Eun Jung Jang; Hana Jeong; Ki Hwan Han; Hyug Moo Kwon; Jeong-Ho Hong; Eun Sook Hwang
Journal:  Mol Cell Biol       Date:  2012-10-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.